PE Tech Report


Like this article?

Sign up to our free newsletter

Juvisé Pharmaceuticals completes €400m refinancing after acquiring Pylera rights

French speciality pharmaceutical company, Juvisé Pharmaceuticals has completed a transaction with AbbVie, regarding the acquisition of the worldwide commercial rights of Pylera.

Financial details of the transaction have not been disclosed.
A €400 million financing was raised with Société Générale, Juvisé Pharmaceuticals historic and lead bank, supporting the funding of this latest acquisition together with the refinancing of its existing debt. Lazard and Latham & Watkins served as financial and legal advisors for Juvisé Pharmaceuticals, whereas White & Case served as legal advisors for Société Générale.

Like this article? Sign up to our free newsletter




Blackstone Private Equity